drugset / Trial / NCT05193071

Early Antiplatelet for Minor Stroke Following Thrombolysis (EAST)

NCT05193071 ↗

Phase 4 Completed 1022 enrolled General Hospital of Shenyang Military Region
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The current guideline recommends to give antithrombotic treatment 24 hours after intravenous thrombolysis in acute ischemic stroke. However, early neurological deterioration will occur in some patients due to no antithrombotic treatment, which is closely associated with poor outcome. The current trial aims to investigate the effectiveness and safety of early antithrombotic treatment after intravenous thrombolysis in minor stroke.

Timeline

Start
2022-07-08
Primary completion
2024-10-25
Completion
2024-10-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 100 mg Oral
Subject Clopidogrel Small molecule 300 mg Oral

Indications